Publications

Found 1 results
Filters: Author is S.M. Mo  [Clear All Filters]
2013
T. T. Yao, Mo, S. M., Liu, L. Y., Lu, H. W., Huang, M. L., and Lin, Z. Q., 5-Aza-2’-deoxycytidine may influence the proliferation and apoptosis of cervical cancer cells via demethylation in a dose- and time-dependent manner, vol. 12, pp. 312-318, 2013.
Andreev DE, Dmitriev SE, Zinovkin R, Terenin IM, et al. (2012). The 5' untranslated region of Apaf-1 mRNA directs translation under apoptosis conditions via a 5' end-dependent scanning mechanism. FEBS Lett. 586: 4139-4143. http://dx.doi.org/10.1016/j.febslet.2012.10.010 PMid:23085065   Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, et al. (2001). Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. 93: 691-699. http://dx.doi.org/10.1093/jnci/93.9.691 PMid:11333291   Christoph F, Kempkensteffen C, Weikert S, Kollermann J, et al. (2006). Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer. Br. J. Cancer 95: 1701-1707. http://dx.doi.org/10.1038/sj.bjc.6603482 PMid:17133271 PMCid:2360762   Chu SH, Ma YB, Feng DF, Zhang H, et al. (2012). Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells. Mol. Med. Report. 5: 138-141.   Dammann R, Takahashi T and Pfeifer GP (2001). The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene 20: 3563-3567. http://dx.doi.org/10.1038/sj.onc.1204469 PMid:11429703   Dreijerink K, Braga E, Kuzmin I, Geil L, et al. (2001). The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 98: 7504-7509. http://dx.doi.org/10.1073/pnas.131216298 PMid:11390984 PMCid:34698   Ferguson AT, Vertino PM, Spitzner JR, Baylin SB, et al. (1997). Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells. J. Biol. Chem. 272: 32260-32266. http://dx.doi.org/10.1074/jbc.272.51.32260 PMid:9405430   Hassler MR, Klisaroska A, Kollmann K, Steiner I, et al. (2012). Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma. Biochimie 94: 2297-2307. http://dx.doi.org/10.1016/j.biochi.2012.05.029 PMid:22687603 PMCid:3480637   Kuzmin I, Gillespie JW, Protopopov A, Geil L, et al. (2002). The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res. 62: 3498-3502. PMid:12067994   Kuzmin I, Liu L, Dammann R, Geil L, et al. (2003). Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res. 63: 1888-1893. PMid:12702579   Kwong J, Lo KW, To KF, Teo PML, et al. (2002). Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin. Cancer Res. 8: 131-137. PMid:11801549   Lee MG, Kim HY, Byun DS, Lee SJ, et al. (2001). Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res. 61: 6688-6692. PMid:11559536   Liu L, Yoon JH, Dammann R and Pfeifer GP (2002). Frequent hypermethylation of the RASSF1A gene in prostate cancer. Oncogene 21: 6835-6840. http://dx.doi.org/10.1038/sj.onc.1205814 PMid:12360410   Melzer IM, Fernandez SB, Bosser S, Lohrig K, et al. (2012). The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential. Cell Death. Differ. 19: 1435-1445. http://dx.doi.org/10.1038/cdd.2012.17 PMid:22388353   Menschikowski M, Platzbecker U, Hagelgans A, Vogel M, et al. (2012). Aberrant methylation of the M-type phospholipase A2 receptor gene in leukemic cells. BMC Cancer 12: 576. http://dx.doi.org/10.1186/1471-2407-12-576 PMid:23217014 PMCid:3561142   Montenegro MF, Saez-Ayala M, Pinero-Madrona A, Cabezas-Herrera J, et al. (2012). Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation. PLoS One 7: e52231. http://dx.doi.org/10.1371/journal.pone.0052231 PMid:23251702 PMCid:3522638   Niimi S, Arakawa-Takeuchi S, Uranbileg B, Park JH, et al. (2012). Cdc6 protein obstructs apoptosome assembly and consequent cell death by forming stable complexes with activated Apaf-1 molecules. J. Biol. Chem. 287: 18573-18583. http://dx.doi.org/10.1074/jbc.M112.347690 PMid:22493447   Ozdemir F, Altinisik J, Karateke A, Coksuer H, et al. (2012). Methylation of tumor suppressor genes in ovarian cancer. Exp. Ther. Med. 4: 1092-1096. PMid:23226780 PMCid:3494110   Sankaranarayanan R and Ferlay J (2006). Worldwide burden of gynaecological cancer: the size of the problem. Best. Pract. Res. Clin. Obstet. Gynaecol. 20: 207-225. http://dx.doi.org/10.1016/j.bpobgyn.2005.10.007 PMid:16359925   Vos MD, Ellis CA, Bell A, Birrer MJ, et al. (2000). Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J. Biol. Chem. 275: 35669-35672. http://dx.doi.org/10.1074/jbc.C000463200 PMid:10998413   Wu Y, Meng L, Wang H, Xu Q, et al. (2006). Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis. Oncol. Rep. 16: 625-629. PMid:16865265